| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |